Les évènements cardiovasculaires sont la première cause de mortalité chez les patients insuffisants rénaux chroniques. Ces complications font suite à des modifications structurelles et fonctionnelles de la paroi vasculaire regroupées sous le terme de vasculopathie urémique. Parallèlement à ces modifications vasculaires, l’urémie s’accompagne d’une accumulation de substances non épurées par le rein appelées toxines urémiques, telles que les produits de la glycation avancée (AGEs) ou les ligands de RAGE. Ces toxines peuvent interagir avec leur récepteur, RAGE, qui est pro- inflammatoire et impliqué dans le remodelage artériel. Cette thèse a consisté en l’étude, chez la souris, du rôle de l’accumulation des ligands de RAGE et de leur interaction avec celui-ci dans le développement de l’athérosclérose, des calcifications vasculaires et de la thrombose artérielle au cours de l’insuffisance rénale chronique (IRC). Dans un premier temps, nous avons montré que l’IRC conduisait à une accumulation des AGEs et des ligands de RAGE sériques et tissulaires, ainsi qu’une augmentation de l’expression de RAGE au sein de la paroi vasculaire participant à la formation des plaques d’athérome. Dans un second temps, nous avons démontré que RAGE participait aux calcifications vasculaires favorisant l’expression de co-transporteur de phosphate inorganique (Pit-1), induisant la différenciation des cellules musculaires lisses en cellules « osteoblast-like ». Enfin, nous avons montré que RAGE participait à la formation d’un thrombus artériel dû à une hyperactivité plaquettaire. En conclusion, cette thèse a permis de renforcer le concept que l’axe ligands de RAGE/RAGE est un acteur important dans la vasculopathie urémique. / Cardiovascular events are the primary cause of morbidity and mortality in chronic kidney disease patients. These complications are due to structural and functional changes in the vascular wall named uraemic vasculopathy. Alongside these vascular changes, uremia is accompanied by the retention of various solutes that are normally excreted by the kidneys called uremic toxins, such as the products of advanced glycation (AGEs) or the ligands of RAGE. These toxins may interact with their receptor, RAGE, which is pro-inflammatory and involved in arterial remodeling. The aim of this thesis was to study, in mice, the role of the accumulation of RAGE ligands and their interaction with it in the development of atherosclerosis, vascular calcification and arterial thrombosis in chronic renal failure (CKD). Initially, we showed that CKD leads to an accumulation of serum and tissue AGEs and RAGE ligands, as well as an increase in RAGE expression in the vascular wall involved in atheroma plaque formation. Secondly, we have demonstrated that RAGE is involved in vascular calcification promoting the expression of inorganic phosphate cotransporter (Pit-1), inducing the differentiation of smooth muscle cells "osteoblast-like". Finally, we showed that RAGE participated in the formation of arterial thrombus due to platelet hyperactivity. In conclusion this thesis consolidates that RAGE-RAGE ligands axis is an important actor in uremic vasculopathy.

Background: Women are more likely to develop age-related cognitive impairment compared with men of the same age. Pregnancy complications, such as preeclampsia (PE), and menopause may contribute to an elevated risk of cognitive decline with aging in women potentially through an adverse impact on vascular function. PE is associated with a heightened risk of hypertension and large elastic artery stiffness (i.e., aortic and carotid arteries) for several years postpartum. Persistent large artery stiffness may be further amplified in women with a history of PE during the menopause transition, which is marked by an accelerated rate of vascular aging. However, large artery stiffness has not been studied extensively in postmenopausal women with a history of PE. Age-related elevations in large artery stiffness are associated with cognitive decline in middle-aged and older adults however, this relation has not been investigated in young women with a history of PE. Moreover, the degree to which elevated large artery stiffness is amplified and associated with reduced cognitive function among postmenopausal women with a history of PE remains unknown. The purpose of this study was to examine the extent to which large elastic artery stiffness is associated with reductions in cognitive function in premenopausal and postmenopausal women with a history of PE. Methods: Large elastic artery stiffness and domains of cognitive function were assessed in young women one year postpartum (n=18, ages 24-41 yrs.) and postmenopausal women (n=19, ages 52-77 yrs.) thirty-five years postpartum. Aortic stiffness was measured via non-invasive applanation tonometry at the carotid and femoral pulse sites and expressed as carotid-femoral pulse wave velocity (cfPWV). Carotid artery stiffness was quantified as beta-stiffness index (β-stiffness) was measured via ultrasonography and carotid tonometry. Cognitive tests were administered to assess cognitive function in immediate and delayed recall, working memory, processing speed, and executive function. Results: Premenopausal women with a history of PE had higher systolic blood pressure (121 ± 4 vs. 101 ± 3 mmHg, p =0.01) one year postpartum but did not differ significantly from controls in cfPWV (6.2 ± 0.4 vs. 5.1 ± 0.2 m/s, p =0.08), β-stiffness (6.1 ± 0.5 vs. 6.1 ± 0.7 U, p =0.97), or cognitive domains of memory, executive function, or processing speed (all p>0.05). Higher systolic blood pressure was associated with lower executive function (r = -0.53, p = 0.05) in young women one year postpartum. Postmenopausal women with a history of PE did not differ from controls in blood pressure, large artery stiffness, or age-adjusted cognitive domains of memory, executive function, or processing speed (all p>0.05). Large artery stiffness was not associated with cognitive function in premenopausal or postmenopausal women. Conclusions: Young women with a history of PE had elevated systolic pressure one year postpartum, which was associated with reductions in executive function. Large artery stiffness was not elevated or related to cognitive function in postmenopausal women with a history of PE. These preliminary findings suggest that young women with a history of PE are susceptible to reductions in selective cognitive domains related to higher blood pressure, but this effect does not appear to extend into the postmenopausal period.

Older age is a primary risk factor for the development of cardiovascular disease in part through the stiffening of the large cardiothoracic elastic arteries (e.g., aorta, carotid arteries). Aging is also associated with reduced cognitive function, cerebrovascular reactivity and brain white matter integrity, but whether these changes in brain structure and function are associated with age-related large artery stiffness remains unclear. In contrast, older adults who have high aerobic fitness demonstrate attenuated large artery stiffness and better cognitive performance compared to their sedentary counterparts, but the effects of aerobic fitness on white matter integrity and cerebrovascular reactivity with aging are conflicting and limited. Moreover, whether high aerobic fitness-associated lower large artery stiffness in older adults is associated with, and perhaps mediates, the beneficial changes in cognitive function and white matter structure remains unknown. The purpose of this study was to investigate the extent to which high aerobic fitness is associated with preserved white matter structure, cerebrovascular reactivity, and cognitive performance in aged individuals, and if these changes in brain structure and function are associated with attenuated large artery stiffness. In young (n=19, 23.6 ± 2.5 years) and old (n=22, 64.4 ± 4.2 years) healthy adults, large elastic artery stiffness was measured by carotid-femoral pulse wave velocity (cfPWV, aortic stiffness) via non-invasive applanation tonometry of carotid and femoral pulse waveforms and carotid artery beta-stiffness index (β-stiffness index) and compliance using high-resolution ultrasound and carotid blood pressure via applanation tonometry. Aerobic fitness was measured as maximal exercise oxygen uptake (VO2max) using respiratory gas analysis on an upright cycle ergometer. Older subjects were stratified as high or low fit based on gender and age VO2max classification. Letter, pattern and N-Back cognitive tests were used to assess processing speed and working memory respectively. Fractional anisotropy (FA) from diffusion tensor images and Blood Oxygenation Level Dependent (BOLD) imaging was used to assess cerebrovascular reactivity (CVR) response to a breath hold and brain activation during a working memory task. The association between large artery stiffness and FA was then assessed using a voxel-wise general linear model approach and a region-of-interest analysis. Our results confirmed age-related increases in cfPWV, carotid β-stiffness index and central (carotid) but not brachial systolic blood pressure, and expected reductions in carotid compliance, VO2max, working memory and processing speed, and in white matter integrity in select brain regions (bilateral cingulate, frontal, occipital, temporal). In contrast, we found no age-associated differences in CVR to breath hold stimulus or change in BOLD response to the N-Back. In our cohort of health adults, we found that the age-related changes in large artery stiffness were not attenuated by high compared with low VO2max. Among older adults, large elastic artery stiffness was not associated with regional white matter integrity or cerebrovascular reactivity in any regions-of-interest. Greater carotid artery compliance and lower β-stiffness index was associated with higher processing speed, while compliance was related to higher d'Prime scores and lower reaction time on the 2-Back task among the older adults. CVR to a breath hold stimulus was not related to any measure of cognitive performance. VO2max was not associated with any measures of vascular function, brain structure, function or cognition, indicating relations between large artery stiffness and cognition were independent of aerobic fitness capacity. Taken together, these data suggest that select measures of cognitive performance, but not white matter structure or CVR, may be susceptible to age-related changes in carotid stiffness/compliance and that are unaffected by aerobic fitness. More work is needed to understand the mechanisms by which age-related declines in carotid artery compliance and increased carotid stiffness are associated with reductions in cognitive function in older adults.

<div>As aging proceeds, the occurrence of cardiovascular diseases increases independent of other risk factors. At atherosclerotic sites, the rise in the senescent cell population was also observed. Patients with Hutchinson Gilford Progeria Syndrome (HGPS) also showed accelerated aging syndromes and extensive atherosclerosis progression, which was due to missense mutations on the LMNA gene that led to the production of progerin, an aberrant lamin A isoform instead of regular lamin A protein. Lamins act as structural and functional components in nuclear lamina, and recent findings suggested that the ectopic expression of mutant lamin A or lamin A precursor (prelamin A) not only caused defects in cell mechanics but also disturbed mechanotransduction pathways involving lamin A, both of which may contribute to vascular dysregulation. Moreover, the observation of the accumulation of prelamin A in normal aged vascular cells further suggests shared dysregulations involving lamin A in the vascular system between aged people and HGPS patients.</div><div>In the vascular system, endothelial cells were well regulated by hemodynamic forces in vivo to maintain vascular homeostasis. Endothelial dysfunction, including impaired vasodilation and increased permeability, was regarded as the initial marker of atherosclerosis. Despite recent advancements and discussions about the potential mechanisms of progerin-induced vascular disorders, how progerin triggers endothelial dysfunction in a mechanical environment as an early event during atherosclerotic lesion formation has not been studied intensively.</div><div>To help answer the gap question, we first set our goal to understand the effect of laminar flow at arterial levels on endothelial lamins as part of the aging process. Spatial and temporal changes in lamin A/C expression were observed as cell passage went up without flow present. As shear stress was applied, lamin A/C expressions were modulated on both transcriptional and translational levels, which were also dependent on PDL. To further examine how progerin was involved in EC functions with a particular focus on the flow effects, we next generated a stable endothelial cell line that expressed progerin as our EC aging model. Endothelial wound repair under laminar flow at different rates was characterized, and differential cell proliferation activities, as well as migration deficiencies in progerin-expressing ECs during the process, were also recognized. Furthermore, we also showed the overactivated mTORC2 pathway and unusual actin polymerization activities in these cells after flow application. Our results reported changes in cell migration by progerin with flow application for the first time and provided potential candidate pathways that were disturbed by progerin under arterial flow, which may help explain the high occurrence of atherosclerotic lesions in HGPS vasculature, even at straight portion. The reported progerin-induced wound recovery defects in endothelial cells in the presence of physiological flow may also suggest a mechanism of how progerin disturbs endothelial integrity and functions under mechanical stimuli in the development of vascular pathologies.</div><div>Further extended studies may help to understand the roles of progerin in initiating atherosclerosis, which will aid in the development of potential therapies for those suffering from prelamin A-associated accelerated aging syndromes.</div>

Le vieillissement cardiaque est fortement associé à l’apparition d’une fibrose pouvant entrainer une dysfonction progressive du remplissage et de l’éjection ventriculaire. Le dépistage du remodelage et du vieillissement cardiovasculaire sont primordiaux afin de proposer des stratégies de prévention et de prises en charge spécifiques visant à retarder l’apparition ou ralentir la progression d’une insuffisance cardiaque à fraction d’éjection préservée. Les outils cliniques, biologiques ou d’imagerie sont insuffisamment performants à l’heure actuelle pour dépister ces modifications précoces ou prédire l’apparition de remodelage ultérieur de façon efficace. La réalisation d’une méta-analyse avec revue de la littérature, nous a permis de montrer la valeur de la déformation myocardique comme marqueur du remodelage cardiovasculaire dans le post-infarctus, mais nous a aussi éclairé sur la complexité du phénomène et le manque de preuves sur sa potentielle valeur additionnelle en pratique clinique. Après avoir validé les différents outils de quantification du remodelage dans nos cohortes, nous avons montré l’importance d’une expertise précise de la morphologie et de la fonction cardiaque lors d’un évènement aigu pour prédire un remodelage ultérieur. Nous avons précisé le rôle de la déformation myocardique dans la quantification de la taille de l’infarctus, sa sévérité et son éventuelle extension au ventricule droit. Enfin, nous avons mis en relation les paramètres de contractilité et de fonction vasculaire en montrant la valeur du couplage ventriculo artériel mesuré en IRM. Ces travaux ouvrent la voie pour une stratégie d’évaluation d’imagerie précoce en post-infarctus pouvant orienter les thérapeutiques de revascularisation et/ou de réhabilitation / Cardiovascular aging is strongly associated with myocardial fibrosis and progressive LV systolic/diastolic dysfunction including vascular stiffening. Cardiac remodeling with left ventricular parietal stress and hypertrophy take place over several years and can ultimately lead to the occurrence of heart failure. Clinical, biological or imaging tools are currently insufficient to detect early changes or to predict the onset of subsequent remodeling in an effective manner. However, if subclinical structural and functional cardiac abnormalities are not detected by conventional echocardiographic techniques, they may be evaluated by others imaging tools with the measurement of myocardial deformation parameters. We performed a systematic review suggesting that deformation imaging is associated with left ventricular volume and function changes regardless the mechanisms and deformation direction. But added strain predictive value over other clinical, biological and imaging variables remains to prove. After validation of various remodeling indices, we proved the add value of a comprehensive assessment of ventricule geometry and function to evaluate remodeling after an acute event. We confirmed the central role of myocardial deformation for infarct size quantification and detect right ventricle extension. Finally, we used vascular function measured by MRI to demonstrate the relation between ventriculo-arterial coupling and remodeling. Further studies are needed to assess the gain in information provided by strain and these new biomarkers.

Thesis ((Ph.D. (Physiology))--North-West University, Potchefstroom Campus, 2010.

Thesis ((Ph.D. (Physiology))--North-West University, Potchefstroom Campus, 2010.

No description available.

L’athérosclérose est à l’origine d’importantes obstructions vasculaires. La sévérité de l’ischémie tissulaire provoquée par l’athérosclérose dépend en partie de la capacité de l’organisme à former de nouveaux vaisseaux (néovascularisation). Les mécanismes de néovascularisation sont modulés par la balance oxydo-réductive. Une exacerbation du stress oxydant est retrouvée dans tous les facteurs de risque cardiovasculaire, et en particulier lors du vieillissement. Au niveau vasculaire, la CuZnSOD est la principale enzyme antioxydante. Cependant, son rôle spécifique dans le vieillissement vasculaire et dans le développement de nouveaux vaisseaux en réponse à l’ischémie n’est pas connu. Nos hypothèses de recherche sont: 1) qu’une absence de CuZnSOD diminue la néovascularisation réparatrice en réponse à l’ischémie 2) que cette diminution de la néovascularisation est dûe au vieillissement de la vasculature affectant à la fois les cellules endothéliales matures et les cellules progénitrices endothéliales. Nous avons démontré qu’une déficience en CuZnSOD diminue significativement la néovascularisation en réponse à l’ischémie. Cette diminution de néovascularisation est associée à une augmentation du stress oxydant et une réduction de la biodisponibilité du NO. La déficience en CuZnSOD réduit significativement le nombre de EPCs (moelle, rate). De plus, ces EPCs présentent une augmentation significative des niveaux de stress oxydant, une diminution de la production de NO et une capacité réduite à migrer et à s’intégrer à un réseau tubulaire. Fait important, il iv est possible d’améliorer la néovascularisation des souris déficientes en CuZnSOD par une supplémentation en EPCs provenant de souris contrôles. Nous avons également démontré que la récupération du flot sanguin suivant l’ischémie est significativement réduite par l’âge. À la fois chez les jeunes et les vieilles souris, la déficience en CuZnSOD mène à une réduction additionnelle de la néovascularisation. Fait intéressant, le potentiel néovasculaire des jeunes souris déficiente en CuZnSOD est similaire à celui des vieilles souris contrôles. Les niveaux de stress oxydant sont également augmentés de façon similaire dans ces deux groupes de souris. L’âge et la déficience en CuZnSOD sont tous deux associés à une réduction du nombre d’EPCs isolées de la moelle et de la rate. L’effet de l’âge seul sur la fonction des EPCs est modeste. Par contre, la déficience en CuZnSOD en condition de vieillissement est associée à d’importants effets délétères sur l’activité fonctionnelle des EPCs. En résumé, nos résultats suggèrent que la protection contre le stress oxydant par la CuZnSOD est essentielle pour préserver la fonction des EPCs et la néovascularisation réparatrice en réponse à l’ischémie. Le défaut de néovascularisation observé en absence de CuZnSOD est associé à un vieillissement vasculaire accéléré. Nos résultats suggèrent que dans le contexte du vieillissement, la CuZnSOD a un rôle encore plus important pour limiter les niveaux de stress oxydant, préserver la fonction des EPCs et maintenir l’intégrité des tissus ischémiques. / When atherosclerotic vascular obstructions are so extensive that direct revascularization techniques cannot be undertaken successfully, the severity of residual tissue ischemia will depend in large part on the ability of the organism to spontaneously develop new blood vessels (neovascularization). The mechanisms involved in neovascularization depend on the oxidative stress balance. Increased oxidative stress is a common feature of all cardiovascular risk factors and particularly aging. In the vascular wall, CuZnSOD is the predominant antioxidant enzyme. Nevertheless, its specific role in vascular aging and new blood vessels formation is currently unknown. Accordingly, we hypotheze that 1) CuZnSOD deficiency reduces neovascularization in response to ischemia 2) this reduction is partly due to vascular aging affecting mature endothelial cells and endothelial progenitor cells. We have demonstrated that CuZnSOD deficiency significantly reduces neovascularization in response to ischemia. This reduction is associated with increased oxidative stress and reduced NO bioavailability. CuZnSOD deficiency significantly decreases EPCs number (bone marrow, spleen). Moreover, these EPCs present significant increased oxidative stress levels, reduced NO production and decreased migration and incorporation into tubular-like structures capacities. Importantly, neovascularization in CuZnSOD deficient-mice can be rescued by an EPCs supplementation from control mice. vii We have also demonstrated that the blood flow recovery following ischemia was significantly reduced with aging. Both in old and young mice, CuZnSOD deficiency led to a further reduction of neovascularization. Interestingly, the resulting neovascularization potential in young CuZnSOD-deficient mouse was similar to that of an older wild type mouse. Oxidative stress levels were also increased to similar levels in these two groups. Both aging and CuZnSOD deficiency were associated with reduced number of bone marrow and peripheral EPCs. The effect of moderate aging alone on specific functional activities of EPCs was modest. However, CuZnSOD deficiency was associated with severe age-dependent defect in EPC fucntional activities. In summary, our resultats suggest that CuZnSOD protection against oxidative stress is essential for EPC functional activities and neovascularization in response to ischemia. The defective neovascularization observed in CuZnSODdeficient mice is associated with accelerated vascular aging. Our results suggest that in aging context, CuZnSOD has a critical role limiting increased oxidative stress and protecting both EPC functional activities and ischemic tissues integrity.

L’athérosclérose est à l’origine d’importantes obstructions vasculaires. La sévérité de l’ischémie tissulaire provoquée par l’athérosclérose dépend en partie de la capacité de l’organisme à former de nouveaux vaisseaux (néovascularisation). Les mécanismes de néovascularisation sont modulés par la balance oxydo-réductive. Une exacerbation du stress oxydant est retrouvée dans tous les facteurs de risque cardiovasculaire, et en particulier lors du vieillissement. Au niveau vasculaire, la CuZnSOD est la principale enzyme antioxydante. Cependant, son rôle spécifique dans le vieillissement vasculaire et dans le développement de nouveaux vaisseaux en réponse à l’ischémie n’est pas connu. Nos hypothèses de recherche sont: 1) qu’une absence de CuZnSOD diminue la néovascularisation réparatrice en réponse à l’ischémie 2) que cette diminution de la néovascularisation est dûe au vieillissement de la vasculature affectant à la fois les cellules endothéliales matures et les cellules progénitrices endothéliales. Nous avons démontré qu’une déficience en CuZnSOD diminue significativement la néovascularisation en réponse à l’ischémie. Cette diminution de néovascularisation est associée à une augmentation du stress oxydant et une réduction de la biodisponibilité du NO. La déficience en CuZnSOD réduit significativement le nombre de EPCs (moelle, rate). De plus, ces EPCs présentent une augmentation significative des niveaux de stress oxydant, une diminution de la production de NO et une capacité réduite à migrer et à s’intégrer à un réseau tubulaire. Fait important, il iv est possible d’améliorer la néovascularisation des souris déficientes en CuZnSOD par une supplémentation en EPCs provenant de souris contrôles. Nous avons également démontré que la récupération du flot sanguin suivant l’ischémie est significativement réduite par l’âge. À la fois chez les jeunes et les vieilles souris, la déficience en CuZnSOD mène à une réduction additionnelle de la néovascularisation. Fait intéressant, le potentiel néovasculaire des jeunes souris déficiente en CuZnSOD est similaire à celui des vieilles souris contrôles. Les niveaux de stress oxydant sont également augmentés de façon similaire dans ces deux groupes de souris. L’âge et la déficience en CuZnSOD sont tous deux associés à une réduction du nombre d’EPCs isolées de la moelle et de la rate. L’effet de l’âge seul sur la fonction des EPCs est modeste. Par contre, la déficience en CuZnSOD en condition de vieillissement est associée à d’importants effets délétères sur l’activité fonctionnelle des EPCs. En résumé, nos résultats suggèrent que la protection contre le stress oxydant par la CuZnSOD est essentielle pour préserver la fonction des EPCs et la néovascularisation réparatrice en réponse à l’ischémie. Le défaut de néovascularisation observé en absence de CuZnSOD est associé à un vieillissement vasculaire accéléré. Nos résultats suggèrent que dans le contexte du vieillissement, la CuZnSOD a un rôle encore plus important pour limiter les niveaux de stress oxydant, préserver la fonction des EPCs et maintenir l’intégrité des tissus ischémiques. / When atherosclerotic vascular obstructions are so extensive that direct revascularization techniques cannot be undertaken successfully, the severity of residual tissue ischemia will depend in large part on the ability of the organism to spontaneously develop new blood vessels (neovascularization). The mechanisms involved in neovascularization depend on the oxidative stress balance. Increased oxidative stress is a common feature of all cardiovascular risk factors and particularly aging. In the vascular wall, CuZnSOD is the predominant antioxidant enzyme. Nevertheless, its specific role in vascular aging and new blood vessels formation is currently unknown. Accordingly, we hypotheze that 1) CuZnSOD deficiency reduces neovascularization in response to ischemia 2) this reduction is partly due to vascular aging affecting mature endothelial cells and endothelial progenitor cells. We have demonstrated that CuZnSOD deficiency significantly reduces neovascularization in response to ischemia. This reduction is associated with increased oxidative stress and reduced NO bioavailability. CuZnSOD deficiency significantly decreases EPCs number (bone marrow, spleen). Moreover, these EPCs present significant increased oxidative stress levels, reduced NO production and decreased migration and incorporation into tubular-like structures capacities. Importantly, neovascularization in CuZnSOD deficient-mice can be rescued by an EPCs supplementation from control mice. vii We have also demonstrated that the blood flow recovery following ischemia was significantly reduced with aging. Both in old and young mice, CuZnSOD deficiency led to a further reduction of neovascularization. Interestingly, the resulting neovascularization potential in young CuZnSOD-deficient mouse was similar to that of an older wild type mouse. Oxidative stress levels were also increased to similar levels in these two groups. Both aging and CuZnSOD deficiency were associated with reduced number of bone marrow and peripheral EPCs. The effect of moderate aging alone on specific functional activities of EPCs was modest. However, CuZnSOD deficiency was associated with severe age-dependent defect in EPC fucntional activities. In summary, our resultats suggest that CuZnSOD protection against oxidative stress is essential for EPC functional activities and neovascularization in response to ischemia. The defective neovascularization observed in CuZnSODdeficient mice is associated with accelerated vascular aging. Our results suggest that in aging context, CuZnSOD has a critical role limiting increased oxidative stress and protecting both EPC functional activities and ischemic tissues integrity.